» Articles » PMID: 27652290

Cats in Positive Energy Balance Have Lower Rates of Adipose Gain When Fed Diets Containing 188 Versus 121 ppm L-Carnitine

Overview
Publisher Wiley
Specialty Biology
Date 2016 Sep 22
PMID 27652290
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

L-carnitine (LC) is included in select adult feline diets for weight management. This study investigated whether feeding adult cats with diets containing either 188 ppm of LC (LC188) or 121 ppm of LC (LC121) and feeding them 120% of maintenance energy requirement (MER) resulted in differences in total energy expenditure (EE), metabolic fuel selection, BW, body composition, and behavior. Cats (n = 20, 4 ± 1.2 yrs) were stratified for BCS and randomly assigned to one of two dietary treatments and fed for 16 weeks. BW was measured weekly, and indirect calorimetry, body composition, physical activity, play motivation, and cognition were measured at baseline and throughout the study. A mixed, repeated measures, ANCOVA model was used. Cats in both treatments gained BW (P < 0.05) throughout the study, with no differences between treatments at any time point (P > 0.05). There were no differences in body composition between groups at baseline; however, body fat (g) and body fat : lean mass ratio were greater in cats fed LC121 in contrast to cats fed LC188 (P < 0.05) on week 16. No other outcomes differed between treatments (P > 0.05). Supplying dietary LC at a dose of at least 188 ppm may be beneficial for the health and well-being of cats fed above MER.

Citing Articles

Dietary choline, but not L-carnitine, increases circulating lipid and lipoprotein concentrations, without affecting body composition, energy expenditure or respiratory quotient in lean and obese male cats during weight maintenance.

Rankovic A, Verton-Shaw S, Shoveller A, Bakovic M, Kirby G, Verbrugghe A Front Vet Sci. 2023; 10:1198175.

PMID: 37565085 PMC: 10410278. DOI: 10.3389/fvets.2023.1198175.


Dietary choline in gonadectomized kittens improved food intake and body composition but not satiety, serum lipids, or energy expenditure.

Godfrey H, Rankovic A, Grant C, Shoveller A, Bakovic M, Abood S PLoS One. 2022; 17(3):e0264321.

PMID: 35298484 PMC: 8929592. DOI: 10.1371/journal.pone.0264321.


Effect of raw and encapsulated policosanol on lipid profiles, blood biochemistry, activity, energy expenditure and macronutrient metabolism of adult cats.

Templeman J, Hogan K, Blanchard A, Marinangeli C, Camara A, Verbrugghe A J Feline Med Surg. 2021; 24(2):177-184.

PMID: 33988050 PMC: 8808005. DOI: 10.1177/1098612X211013738.


Modelling net energy of commercial cat diets.

Asaro N, Seymour D, Mansilla W, Cant J, Zijlstra R, Berendt K PLoS One. 2019; 14(6):e0218173.

PMID: 31185052 PMC: 6559639. DOI: 10.1371/journal.pone.0218173.

References
1.
Center S, Harte J, Watrous D, Reynolds A, Watson T, Markwell P . The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine. J Vet Intern Med. 2000; 14(6):598-608. DOI: 10.1892/0891-6640(2000)014<0598:tcameo>2.3.co;2. View

2.
Blanchard G, Paragon B, Milliat F, Lutton C . Dietary L-carnitine supplementation in obese cats alters carnitine metabolism and decreases ketosis during fasting and induced hepatic lipidosis. J Nutr. 2002; 132(2):204-10. DOI: 10.1093/jn/132.2.204. View

3.
Graziano F, Bisonni R, Catalano V, Silva R, Rovidati S, Mencarini E . Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer. 2002; 86(12):1854-7. PMC: 2375434. DOI: 10.1038/sj.bjc.6600413. View

4.
Ando S, Kobayashi S, Waki H, Kon K, Fukui F, Tadenuma T . Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine. J Neurosci Res. 2002; 70(3):519-27. DOI: 10.1002/jnr.10443. View

5.
Montgomery S, Thal L, Amrein R . Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol. 2003; 18(2):61-71. DOI: 10.1097/00004850-200303000-00001. View